As the largest resource of information specific to women's brain health, we are sure you will find what you are looking for, and promise that you will discover new information.
Published on: June 24, 2019
by Elinor Aspegren for USA Today:
A study out of the University of Nottingham in the United Kingdom found that there is a link between dementia and certain classes of anticholinergic drugs.
The drugs, particularly antidepressants, bladder antimuscarinics, antipsychotics and antiepileptic drugs, resulted in nearly “50% increased odds of dementia,” according to the study published Monday in the peer-reviewed JAMA Internal Medicine journal.
Doctors prescribe these kinds of drugs to treat a variety of conditions, including chronic obstructive pulmonary disease, bladder conditions, allergies, gastrointestinal disorders and symptoms of Parkinson’s disease.
The risk is only associated with a 1,095 daily doses within a 10-year period, which is equivalent to an older adult taking a strong anticholinergic medication daily for at least three years.
“The study is important because it strengthens a growing body of evidence showing that strong anticholinergic drugs have long term associations with dementia risk,” said study author Carol Coupland, professor of medical statistics in primary care at the University of Nottingham.
“It also highlights which types of anticholinergic drugs have the strongest associations. This is important information for physicians to know when considering whether to prescribe these drugs,” she told CNN. “This is an observational study so no firm conclusions can be drawn about whether these anticholinergic drugs cause dementia.”
The study warns people against stopping any of the medications listed without consulting their doctors.
The researchers found no significant increases in dementia risk associated with antihistamines, skeletal muscle relaxants, gastrointestinal antispasmodics, antiarrhythmics, or antimuscarinic bronchodilators, but associations were found among other classes of anticholinergic drugs.
An estimated 47 million people worldwide were living with dementia in 2015, while in the United States around 5.7 million people have Alzheimer dementia, according to the study.
Scientists have long viewed anticholingergic drugs to be associated with an increased risk of dementia. A full list of anticholinergic drugs can be found here.
Having a paying job might shield women from memory loss decades later, according to a new study. That’s because paid work may offer mental stimulation, financial benefits and social connections that could limit declines in...
New research reported at the Alzheimer’s Association International Conference (AAIC) 2019 in Los Angeles evaluates drug and non-drug treatments to improve sleep patterns in persons with Alzheimer’s disease or other dementias. Sleep disruption is a common behavioral challenge that...
Sharon Stone, Rumer Willis, Andie MacDowell and Jane Seymour all gathered at the Eric Buterbaugh Gallery on Wednesday night for an event to discuss Women’s Brain Health Initiative, a charitable organization dedicated to...
The material presented through the Think Tank feature on this website is in no way intended to replace professional medical care or attention by a qualified practitioner. WBHI strongly advises all questioners and viewers using this feature with health problems to consult a qualified physician, especially before starting any treatment. The materials provided on this website cannot and should not be used as a basis for diagnosis or choice of treatment. The materials are not exhaustive and cannot always respect all the most recent research in all areas of medicine.